ALARA objectives deemed 'misguided,' 'detrimental'
'ICE will become the standard way of doing it over the next couple of years'
Equipped with a series of improved features
New study will compare IMRT to IMPT for head and neck cancer
Researchers say it shows promise in preclinical test
Basing treatment decisions on genomics
Machine learning meets breast cancer expertise
Former executive at Novartis AG appointed CEO of Avita Medical Limited
Getting down to the cellular level with precision diagnostics
An industry spurred by one of the world's greatest public health challenges
Research led by Philips and two European universities
